BPC-157 is one of the most talked-about peptides online. Sellers and social media posts link it to faster healing of tendons, muscles and the gut. But what does the research actually say? The short answer: interesting animal results, and very little human data.
What BPC-157 is
BPC-157 is a synthetic peptide, meaning it is made in a lab. It is a short fragment based on a protein found in human stomach juice. It is not an FDA-approved drug, and no product containing it has gone through FDA review for safety or effectiveness.
What the animal studies show
Most BPC-157 research has been done in animals, mainly rats. Those studies have looked at healing of tendons, muscles, bones and the digestive tract, and many reported positive results. That is why the peptide gets so much attention.
Animal results are a starting point, not an answer. Many treatments that look good in animals do not work the same way in people, or turn out to have side effects that only show up in human studies.
What the human studies show
Very little. A 2025 review in Current Reviews in Musculoskeletal Medicine found only three published human studies:
- A small look-back study of people who received knee injections for pain.
- A small pilot study in people with a bladder pain condition.
- A safety study that gave the peptide by IV to just two healthy adults.
None of these was a large, controlled trial, which is the kind of study needed to show a treatment works and is safe. The review’s authors called human data “exceedingly sparse” and said BPC-157 should not be recommended for musculoskeletal use until better trials are done.
Where it stands with regulators
- FDA: In April 2026, FDA removed BPC-157 from its list of compounding substances that may pose significant safety risks. That happened because the nominations were withdrawn, not because of new safety findings. It did not make BPC-157 eligible for compounding.
- Advisory vote: In July 2026, an FDA advisory committee voted 8 to 6, with one abstention, to recommend allowing BPC-157 in pharmacy compounding. FDA staff had recommended against it. The vote is advisory, and as of October 2026 FDA has not made a final decision.
- Sport: The World Anti-Doping Agency (WADA) bans BPC-157 at all times.
Products sold online as “research peptides” carry extra risks. They are not made to medicine standards and may contain the wrong substance or amount, or contaminants.
The bottom line
BPC-157 has promising animal research, but there is not enough human evidence to know whether it works or is safe. If you are dealing with an injury or gut problem, talk with a clinician about treatments that have been tested in people.